Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-05

Clinical Trial Update: Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria [NA]

View source ↗

Summary

A clinical trial update noting the withdrawal of NCT03142217, a study characterizing dysarthria in Huntington's disease conducted by Centre Hospitalier Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Dysarthria, Huntington Disease | NA | Status: WITHDRAWN